ENO1 as a Biomarker of Breast Cancer Progression and Metastasis: A Bioinformatic Approach Using Available Databases [0.03%]
ENO1作为乳腺癌进展和转移生物标志物的生物信息学方法研究
Athina Giannoudis,Alistair Heath,Vijay Sharma
Athina Giannoudis
Background: Metabolic reprogramming is one of the hallmarks of cancer, and in breast cancer (BC), several metabolic enzymes are overexpressed and overactivated. One of these, Enolase 1 (ENO1), catalyses glycolysis and is ...
Quality of Life in Female Breast Cancer Patients and Survivors in a South African Municipality [0.03%]
南非一个市辖区的女性乳腺癌患者和生存者的生存质量
Rebecca Wilkinson,Lynn Smith
Rebecca Wilkinson
Background: Breast cancer diagnosis and treatment processes affect patients physically and mentally, and have an impact on their quality of life, even years after receiving treatment. ...
Serum and Fecal Metabolite Profiles Linking With Gut Microbiome in Triple-Negative Breast Cancer Patients [0.03%]
三阴性乳腺癌患者的血清及粪便代谢谱与肠道菌群的关系研究
Jiawei Liu,Jing Shi,Tingting Zhang et al.
Jiawei Liu et al.
Background: Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by poor prognosis due to the absence of effective targeted therapies. Emerging evidence indicates that the gut microbiota and it...
Higher 10-Year Survival with Breast-Conserving Therapy over Mastectomy for Women with Early-Stage (I-II) Breast Cancer: Analysis of the CDC Patterns of Care Data Base [0.03%]
早期乳腺癌患者保乳手术10年生存率高于乳房切除术：基于疾病控制中心治疗模式数据库的分析研究
Pratibha Shrestha,Mei-Chin Hsieh,Tekeda Ferguson et al.
Pratibha Shrestha et al.
Background: Studies in the United States are scarce that assess the survival differences between breast-conserving surgery plus radiation (Breast-Conserving Therapy; BCT) and mastectomy groups using population-based data ...
Therapeutic Opportunities in Breast Cancer by Targeting Macrophage Migration Inhibitory Factor as a Pleiotropic Cytokine [0.03%]
趋化因子巨噬细胞迁移抑制因子在乳腺癌治疗中的机遇研究phemotropic cytokine)作为多效性细胞因子)在乳腺癌治疗中的机遇研究
Ali Khezrian,Ali Shojaeian,Armin Khaghani Boroujeni et al.
Ali Khezrian et al.
As a heterogeneous disease, breast cancer (BC) has been characterized by the uncontrolled proliferation of mammary epithelial cells. The tumor microenvironment (TME) also contains inflammatory cells, fibroblasts, the extracellular matrix (E...
Breast Cancer Awareness and Uptake of Breast Cancer Screening Services Among Undergraduate Female Students in the Oldest University of Tanzania: A Cross-Sectional Study [0.03%]
坦桑尼亚最古老大学在校女大学生的乳腺癌认知及筛查利用情况横断面调查研究
Mary Mally,Novatus Tesha,Amani Anaeli
Mary Mally
Background: Breast cancer is the leading cause of cancer-related death among women worldwide. Mortality from breast cancer can be reduced through early detection and prevention. Despite the availability of breast cancer s...
Fertility and Pregnancy-Related Issues in Young BRCA Carriers With Breast Cancer [0.03%]
年轻BRCA突变携带者乳腺癌患者的生育及妊娠相关问题
Isotta Martha Magaton,Luca Arecco,Elene Mariamidze et al.
Isotta Martha Magaton et al.
Approximately 10% to 15% of breast cancer cases in young women are diagnosed in patients harbouring germline (g) pathogenic or likely pathogenic variants (PVs) in the BReast CAncer 1 (BRCA1) or BReast CAncer 2 (BRCA2) genes. Preclinical and...
The Feasibility and Reliability of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Negative Axillary Lymph Nodes-A Meta-analysis [0.03%]
新辅助化疗后前哨淋巴结活检的可行性和可靠性： meta分析
Mengjie Yu,Yu Liu,Zenan Huang et al.
Mengjie Yu et al.
Background: The application of sentinel lymph node biopsy (SLNB) has expanded from early breast cancer to locally advanced breast cancer with neoadjuvant chemotherapy (NAC). For patients with negative axillary lymph nodes...
Association Between Ki-67 Proliferative Index and Oncotype-Dx Recurrence Score in Hormone Receptor-Positive, HER2-Negative Early Breast Cancers. A Systematic Review of the Literature [0.03%]
Ki-67增殖指数与激素受体阳性、HER2阴性早期乳腺癌的OncoType DX复发评分之间的相关性：文献系统综述
Mehwish Mooghal,Muhammad Ali Akbar Khan,Mirza Rameez Samar et al.
Mehwish Mooghal et al.
Background: Oncotype-Dx (ODx) is a 21-gene assay used as a prognostic and predictive tool for hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative, node-negative, or 1 to 3 lymph nod...
Estrogen Receptor Is Required for Metformin-Induced Apoptosis in Breast Cancer Cells Under Hyperglycemic Conditions [0.03%]
雌激素受体是_hyperglycemia_下二甲双胍诱导乳腺癌细胞凋亡的关键因素
Andisyah Putri Sekar,Septia Nurmala,Eiji Matsuura et al.
Andisyah Putri Sekar et al.
Backgrounds: About 25% to 30% of estrogen receptor (ER)-positive breast cancer patients develop resistance to endocrine therapy. Human epidermal growth factor receptor 2 (HER2) has been shown to cooperate with several gro...